Tag: generics
Repurchase of Biogaran (generics): Gabriel Attal promises “exceptional vigilance”
The prospect of a possible sale of the Biogaran laboratory, which presents one box of medicines in eight sold in pharmacies and nearly a third of generic medicines in France,…
Generics: the State “vigilant” on the possible sale of Biogaran
Europe 1 with AFP 4:28 p.m., April 18, 2024 The Minister Delegate in charge of Industry, Roland Lescure explained Thursday that the State is “following and being very vigilant” on…
Savings potential “significant” – Federal Council wants to save 250 million with generics funding – News
Generics are cheaper compared to original preparations. In addition, patients’ deductibles increase if they choose the more expensive product despite having the same active ingredient. The Federal Council wants to…
Generics division is spun off: Novartis sends Sandoz to the stock exchange
Generics division is spun off Novartis is going public with Sandoz 8/18/2023 8:58 am The Swiss pharmaceutical company Novartis is streamlining its business. This also includes the separation from the…
Generics subsidiary – Novartis separates from Sandoz – News
The Basel pharmaceutical company Novartis separates from Sandoz. The generics manufacturer is to become an independent company. The company’s headquarters will remain in Switzerland. According to Novartis, the transaction should…
Blackstone and Carlyle Consider Joint Bid on Novartis Generics Business – Bloomberg News
Blackstone and Carlyle Consider Joint Bid for Novartis Generic Business – Bloomberg News | Photo credits: Copyright ® Novartis AG Feb 1 (Reuters) – Blackstone and Carlyle are in talks…
Corona and price pressure: Novartis is examining the future of the generics subsidiary Sandoz
Tuesday, October 26, 2021 Corona and price pressure Novartis is examining the future of the generics subsidiary Sandoz It generates every fifth euro – but generates comparatively little income: The…